hhs_forecastForecastirf7uq31d82
nanodrop
Department of Health and Human Services.Food and Drug Administration.75F401.75F402
- Est. solicitation
- Jun 1, 2027
- Date posted
- —
- Source
- Open forecast
Description
The REVOLVE R4 microscope provides both upright and inverted imaging in a single instrument, enabling versatile brightfield and multi-channel fluorescence imaging of cultured cells and tissue specimens used in the characterization and evaluation of gene therapy products while reducing the need for multiple microscopes. It will replace a brightfield-only microscope currently housed in the Kemaladewi Laboratory, Gene Therapy Immunology Branch (GTIB), significantly expanding imaging capabilities and ensuring continued support for research and regulatory science activities.
Planning details
- Estimated value
- > $10K and <= $25K
- Est. solicitation date
- Jun 1, 2027
- Anticipated award
- Sep 1, 2027
Classifications
- NAICS334516
- PSC334516